DLA Piper has advised Brighter AB (publ) (Brighter) in connection with Brighter's securement of external financing through issuance of convertible notes with warrants attached in up to eight tranches of a total amount of SEK 100 million spread over 36 months.

The tranches are subscribed by a fund managed by L1 Capital Pty, Ltd. which is a boutique fund manager based in Australia but that also operates in the US and in Europe. In connection with this transaction, Brighter will also issue free warrants to its existing shareholders to protect them against dilution. The warrants will be admitted to trading on Nasdaq First North.

Brighter develops healthtech solutions with its data-driven mobile health services. Through its intellectual property and its first launch Actiste®, Brighter creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter's share is listed on Nasdaq First North.

DLA Piper's team consisted of Peter Näslund, Louise St Cyr Linnarsson and Jesper Lindbom.